This Is MS Multiple Sclerosis Community: Knowledge & Support
Welcome to the world's leading forum on Multiple Sclerosis research, support, and knowledge. For over 10 years, This is MS has provided an unbiased community dedicated to Multiple Sclerosis patients, caregivers, and affected loved ones.
The Company has delayed filing an Investigational New Drug (IND) application for rHIgM22, pending completion of a bioactivity assay. Accorda has been carrying out preclinical studies on rHIgM22 for many years, but human trils are still away. ...Looking at the ongoing trials, it seems to me that no mouse with MS will exist in a few years, but what about humans...
This site does not offer, or claim to offer, medical, legal, or professional advice.
All treatment decisions should always be made with the full knowledge of your physicians.
This is MS does not create, endorse, or republish any content.
All postings are the responsibility of the poster. All logos and trademarks in this site are property of their respective owners. All users must respect our rules for intellectual property rights.